Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus

World Journal of Stem Cells

Volumn 8, Issue 7, 2016, Pages 223-230

  Shroff, Geeta ^a  

^a Nutech Mediworld   (India)

Author keywords

Glycated hemoglobin; Human embryonic stem cells; Insulin; Nutech functional scoring scale; Type 2 diabetes mellitus

Indexed keywords

EID: 85014367472     PISSN: None     EISSN: 19480210     Source Type: Journal    
DOI: 10.4252/wjsc.v8.i7.223     Document Type: Article

References (47)

1. Czubak P, Bojarska-Junak A, Tabarkiewicz J, Putowski L. A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cells. J Diabetes Res 2014; 2014: 628591 [PMID: 25405207 DOI: 10.1155/2014/628591]
2. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001; 50: 1691-1697 [PMID: 11473026 DOI: 10.2337/ diabetes.50.8.1691]
3. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun 2011; 12: 239-250 [PMID: 21390053 DOI: 10.1038/gene.2011.14]
4. Khorsandi L, Khodadadi A, Nejad-Dehbashi F, Saremy S. Threedimensional differentiation of adipose-derived mesenchymal stem cells into insulin-producing cells. Cell Tissue Res 2015; 361: 745-753 [PMID: 25795142 DOI: 10.1007/s00441-015-2140-9]
5. Barclay RS. Type 2 diabetes is common and hard to treat. Now, a cure may be on the horizon. Healthline News, 2015. Available from: URL: http://www.healthline.com/health-news/combination-of-stemcell-drug-therapy-could-reverse-type 2-diabetes-051915
6. National Institutes of Health. Stem cells and diabetes. Bethesda, USA, 2001. [accessed 2015 Oct 15]. Available from: URL: http:// stemcells.Nih.Gov/info/scireport/pages/chapter7.Aspx
7. Bromberg JS, Kaplan B, Halloran PF, Robertson RP. The islet transplant experiment: time for a reassessment. Am J Transplant 2007; 7: 2217-2218 [PMID: 17845557 DOI: 10.1111/j.1600-6143.2007.01957. x]
8. Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol 2013; 9: 555-562 [PMID: 23897173 DOI: 10.1038/nrendo.2013.138]
9. Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014; 371: 313-325 [PMID: 24931572 DOI: 10.1056/ NEJMoa1314474]
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853 [PMID: 9742976 DOI: 10.1016/S0140-6736(98)07019-6]
11. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 1999; 48: 643-648 [PMID: 10594464 DOI: 10.1046/j.1365-2125.1999.00092.x]
12. Mazzola N. Review of current and emerging therapies in type 2 diabetes mellitus. Am J Manag Care 2012; 18: S17-S26 [PMID: 22559854]
13. Zhou Y, Hu Q, Chen F, Zhang J, Guo J, Wang H, Gu J, Ma L, Ho G. Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets. Dis Model Mech 2015; 8: 1625-1633 [PMID: 26398949 DOI: 10.1242/dmm.021857]
14. Liang D, Zhang Y, Han J, Wang W, Liu Y, Li J, Jiang X. Embryonic stem cell-derived pancreatic endoderm transplant with MCT1-suppressing miR-495 attenuates type II diabetes in mice. Endocr J 2015; 62: 907-920 [PMID: 26211669 DOI: 10.1507/endocrj. EJ15-0186]
15. Rezania A, Bruin JE, Riedel MJ, Mojibian M, Asadi A, Xu J, Gauvin R, Narayan K, Karanu F, O'Neil JJ, Ao Z, Warnock GL, Kieffer TJ. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012; 61: 2016-2029 [PMID: 22740171 DOI: 10.2337/db11-1711]
16. Lee SH, Hao E, Savinov AY, Geron I, Strongin AY, Itkin-Ansari P. Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 2009; 87: 983-991 [PMID: 19352116 DOI: 10.1097/TP.0b013e31819c86ea]
17. Hayek A, Beattie GM. Experimental transplantation of human fetal and adult pancreatic islets. J Clin Endocrinol Metab 1997; 82: 2471-2475 [PMID: 9253320 DOI: 10.1210/jcem.82.8.4151]
18. Hua XF, Wang YW, Tang YX, Yu SQ, Jin SH, Meng XM, Li HF, Liu FJ, Sun Q, Wang HY, Li JY. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes. PLoS One 2014; 9: e102198 [PMID: 25009980 DOI: 10.1371/ journal.pone.0102198]
19. Shroff G. A novel approach of human embryonic stem cells therapy in treatment of friedrich's ataxia. Int J Case Rep Images 2015; 6: 261-266 [DOI: 10.5348/ijcri-201503-CS-10054]
20. Shroff G, Gupta R. Human embryonic stem cells in the treatment of patients with spinal cord injury. Ann Neurosci 2015; 22: 208-216 [DOI: 10.5214/ans.0972.7531.220404]
21. Shroff G. Establishment and characterization of neuronal cell line derived from a 2-cell stage human embryo. Int J Recent Sci Res 2015; 6: 3730-3738
22. Shroff G, Gupta A, Barthakur JK. Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. J Transl Med 2014; 12: 318 [PMID: 25496119 DOI: 10.1186/ s12967-014-0318-7]
23. Shroff G, Das L. Human embryonic stem cell therapy in cerebral palsy children with cortical visual impairment: A case series of 40 patients. J Cell Sci Ther 2014; 5: 189 [DOI: 10.4172/2157-7013.1000189]
24. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994; 62: 1011-1017 [PMID: 7926111]
25. Mo M, Zhong W, Zhao G, Ruan Y, Zhang H, Shi L, Lu D, Yang Q, Li Y, Jiang Q, Li R, Xu WH. Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults. BMC Endocr Disord 2013; 13: 44 [PMID: 24099651 DOI: 10.1186/1472-6823-13-44]
26. Shroff G. A scoring system to assess patients with diabetes: Nutech functional score. J Diabetes Mellitus 2015; 5: 245-251 [DOI: 10.4236/jdm.2015.54030]
27. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: A prerequisite for cell therapy. J Mol Cell Cardiol 2008; 45: 514-522 [DOI: 10.1016/j.yjmcc.2008.01.004]
28. Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO. Managing type 2 diabetes: going beyond glycemic control. J Manag Care Pharm 2008; 14: s2-19 [PMID: 18597582]
29. Cerveny JD, Leder RD, Weart CW. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus. Ann Pharmacother 1998; 32: 896-905 [PMID: 9762378 DOI: 10.1345/ aph.17375]
30. Weir G. Do stem cells hold the key to a future cure for diabetes? Diabetes Voice 2008. Available from: URL: http://www.idf.org/ diabetesvoice/articles/do-stem-cells-hold-the-key-to-a-future-curefor-diabetes
31. Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA. Generation of functional human pancreatic β cells in vitro. Cell 2014; 159: 428-439 [PMID: 25303535 DOI: 10.1016/j.cell.2014.09.040]
32. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22: 448-456 [PMID: 15277692 DOI: 10.1634/ stemcells.22-4-448]
33. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24: 221-229 [PMID: 16109762 DOI: 10.1634/stemcells.2005-0188]
34. Chatterjee S, Sharma A, Lichstein E, Mukherjee D. Intensive glucose control in diabetics with an acute myocardial infarction does not improve mortality and increases risk of hypoglycemia-a metaregression analysis. Curr Vasc Pharmacol 2013; 11: 100-104 [PMID: 22724474 DOI: 10.2174/1570161111309010100]
35. Mishra PK, Singh SR, Joshua IG, Tyagi SC. Stem cells as a therapeutic target for diabetes. Front Biosci (Landmark Ed) 2010; 15: 461-477 [PMID: 20036830]
36. Leung PS, Ng KY. Current progress in stem cell research and its potential for islet cell transplantation. Curr Mol Med 2013; 13: 109-125 [PMID: 22834839 DOI: 10.2174/1566524011307010109]
37. Soria B, Roche E, Berná G, León-Quinto T, Reig JA, Martín F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-162 [PMID: 10868930 DOI: 10.2337/diabetes.49.2.157]
38. Gu C, Huang S, Gao D, Wu Y, Li J, Ma K, Wu X, Fu X. Angiogenic Effect of Mesenchymal Stem Cells as a Therapeutic Target for Enhancing Diabetic Wound Healing. Int J Low Extrem Wounds 2014; 13: 88-93 [PMID: 24861091 DOI: 10.1177/1534734614534977]
39. Rosa SB, Voltarelli JC, Chies JAB, Pranke P. The use of stem cells for the treatment of autoimmune diseases. Braz J Med Biol Res 2007; 40: 1579-1597 [DOI: 10.1590/S0100-879X2006005000166]
40. El-Badri N, Ghoneim MA. Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges. J Nucleic Acids 2013; 2013: 194858 [PMID: 23762531 DOI: 10.1155/2013/194858]
41. Bhansali A, Upreti V, Khandelwal N, Marwaha N, Gupta V, Sachdeva N, Sharma RR, Saluja K, Dutta P, Walia R, Minz R, Bhadada S, Das S, Ramakrishnan S. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev 2009; 18: 1407-1416 [PMID: 19686048 DOI: 10.1089/scd.2009.0164]
42. Stem cell therapy for type 2 diabetes mellitus. 2010. ClinicalTrials. gov Identifier: NCT01142050. Available from: URL: https:// clinicaltrials.gov/ct2/show/NCT01142050?rank=6&term=stem%20c ells%20and%20diabetes%20type%202
43. Davey GC, Patil SB, O'Loughlin A, O'Brien T. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front Endocrinol (Lausanne) 2014; 5: 86 [PMID: 24936198 DOI: 10.3389/fendo.2014.00086]
44. Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med 2010; 48: 609-614 [PMID: 20464776 DOI: 10.1515/CCLM.2010.144]
45. Mack R, Skurnick B, Sterling-Jean Y, Pedra-Nobre M, Bigg D. Fasting insulin levels as a measure of insulin resistance in American blacks. J Med 2003; 34: 31-38 [PMID: 17682309]
46. Snehalatha C, Ramachandran A, Satyavani K, Vijay V. Limitations of glycosylated haemoglobin as an index of glucose intolerance. Diabetes Res Clin Pract 2000; 47: 129-133 [PMID: 10670913 DOI: 10.1016/S0168-8227(99)00109-6]
47. Cox ME, Edelman D. Tests for screening and diagnosis of type 2 diabetes. Clinical Diabetes 2009; 27: 132-138 [DOI: 10.2337/ diaclin.27.4.132]